These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37543065)

  • 1. Assessing extent of brain penetration in vivo (K
    Langthaler K; Jones CR; Brodin B; Bundgaard C
    Eur J Pharm Sci; 2023 Nov; 190():106554. PubMed ID: 37543065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios.
    Sato S; Matsumiya K; Tohyama K; Kosugi Y
    AAPS J; 2021 Jun; 23(4):81. PubMed ID: 34085128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse.
    Kido Y; Nanchi I; Fusamae Y; Matsuzaki T; Akazawa T; Sawada H; Iwasaki M; Nishida K; Tsuchiya E; Okuda T
    Drug Metab Pharmacokinet; 2022 Feb; 42():100426. PubMed ID: 34974334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier.
    Summerfield SG; Zhang Y; Liu H
    J Pharmacol Exp Ther; 2016 Aug; 358(2):294-305. PubMed ID: 27194478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative investigation of the brain-to-cerebrospinal fluid unbound drug concentration ratio under steady-state conditions in rats using a pharmacokinetic model and scaling factors for active efflux transporters.
    Kodaira H; Kusuhara H; Fuse E; Ushiki J; Sugiyama Y
    Drug Metab Dispos; 2014 Jun; 42(6):983-9. PubMed ID: 24644297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
    Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
    Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical Application of Rodent Transporter Knockout Models to Assess Brain Penetration in Drug Discovery.
    Eneberg E; Jones CR; Jensen T; Langthaler K; Bundgaard C
    Drug Metab Bioanal Lett; 2022; 15(1):12-21. PubMed ID: 35196975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
    Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbound Brain-to-Plasma Partition Coefficient, K
    Loryan I; Reichel A; Feng B; Bundgaard C; Shaffer C; Kalvass C; Bednarczyk D; Morrison D; Lesuisse D; Hoppe E; Terstappen GC; Fischer H; Di L; Colclough N; Summerfield S; Buckley ST; Maurer TS; Fridén M
    Pharm Res; 2022 Jul; 39(7):1321-1341. PubMed ID: 35411506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Göttingen minipigs for the prediction of human pharmacokinetic profiles after intravenous drug administration.
    Ding N; Yamamoto S; Chisaki I; Nakayama M; Matsumoto SI; Hirabayashi H
    Drug Metab Pharmacokinet; 2021 Dec; 41():100408. PubMed ID: 34710650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems.
    Liu H; Dong K; Zhang W; Summerfield SG; Terstappen GC
    Drug Discov Today; 2018 Jul; 23(7):1357-1372. PubMed ID: 29548981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
    Peng J; Ladumor MK; Unadkat JD
    Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Prediction of Human Steady-State Unbound Brain-to-Plasma Concentration Ratio of P-gp Substrates Using the Proteomics-Informed Relative Expression Factor Approach.
    Storelli F; Anoshchenko O; Unadkat JD
    Clin Pharmacol Ther; 2021 Aug; 110(2):432-442. PubMed ID: 33675056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the Tissue Composition-Based Model to Minipig for Predicting the Volume of Distribution at Steady State and Dermis-to-Plasma Partition Coefficients of Drugs Used in the Physiologically Based Pharmacokinetics Model in Dermatology.
    Poulin P; Collet SH; Atrux-Tallau N; Linget JM; Hennequin L; Wilson CE
    J Pharm Sci; 2019 Jan; 108(1):603-619. PubMed ID: 30222978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation.
    Anoshchenko O; Storelli F; Unadkat JD
    Drug Metab Dispos; 2021 Oct; 49(10):919-928. PubMed ID: 34426410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the role and quantitative impact of breast cancer resistance protein on drug distribution into brain and CSF in rats.
    Katagiri Y; Kawaguchi H; Umemura K; Tadano J; Miyawaki I; Takano M
    Drug Metab Pharmacokinet; 2022 Feb; 42():100430. PubMed ID: 34896751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys.
    Uchida Y; Wakayama K; Ohtsuki S; Chiba M; Ohe T; Ishii Y; Terasaki T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):578-88. PubMed ID: 24947467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, K
    Lawrenz M; Svensson M; Kato M; Dingley KH; Chief Elk J; Nie Z; Zou Y; Kaplan Z; Lagiakos HR; Igawa H; Therrien E
    J Chem Inf Model; 2023 Jun; 63(12):3786-3798. PubMed ID: 37267072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.